Risk factors for visual field damage progression in normal-tension glaucoma eyes

被引:0
|
作者
L. Daugeliene
Tetsuya Yamamoto
Yoshiaki Kitazawa
机构
[1] Department of Ophthalmology,
[2] Gifu University School of Medicine,undefined
[3] 40 Tsukasa-machi,undefined
[4] Gifu-shi 500-8705,undefined
[5] Japan Tel. +81-58-267-2637; Fax +81-58-265-9012; e-mail lina-gif@umin.u-tokyo.ac.jp,undefined
关键词
Visual Field; Glaucoma; Channel Blocker; Intraocular Pressure; Stepwise Regression;
D O I
暂无
中图分类号
学科分类号
摘要
· Background: This study was carried out to evaluate intraocular or systemic factors associated with the visual field damage progression in eyes with normal-tension glaucoma (NTG). · Patients and methods: Forty-seven NTG eyes with a minimum follow-up of 5 years were enrolled into the retrospective study. A stepwise regression analysis was performed to correlate the visual field damage progression, expressed as the mean deviation (MD) change per year, with several independent clinical factors including age, history of disc hemorrhage, initial MD, mean intraocular pressure (IOP), peak IOP, diurnal fluctuation of IOP, presence of a β zone of peripapillary atrophy, and use of Ca2+-channel blockers. · Results: Statistical analysis revealed that non-use of Ca2+-channel blockers (P=0.01), peripapillary atrophy (P=0.03) and disc hemorrhage (P=0.04) were associated with visual loss progression. · Conclusions: Risk factors unrelated to IOP were suggested to be associated with progression of visual field loss. Systemic use of Ca2+-channel blockers has a favorable effect on visual field prognosis in NTG eyes.
引用
收藏
页码:105 / 108
页数:3
相关论文
共 50 条
  • [1] Risk factors for visual field damage progression in normal-tension glaucoma eyes
    Daugeliene, L
    Yamamoto, T
    Kitazawa, Y
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1999, 237 (02) : 105 - 108
  • [2] FACTORS CONTRIBUTING TO THE PROGRESSION OF VISUAL-FIELD DAMAGE IN EYES WITH NORMAL-TENSION GLAUCOMA
    ARAIE, M
    SEKINE, M
    SUZUKI, Y
    KOSEKI, N
    [J]. OPHTHALMOLOGY, 1994, 101 (08) : 1440 - 1444
  • [3] Risk factors for progression of visual field abnormalities in normal-tension glaucoma
    Drance, S
    Anderson, DR
    Schulzer, M
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 131 (06) : 699 - 708
  • [4] Prognostic Factors for Progression of Visual Field Damage in Patients with Normal-Tension Glaucoma
    Takako Nakagami
    Yoshio Yamazaki
    Fukuko Hayamizu
    [J]. Japanese Journal of Ophthalmology, 2006, 50 : 38 - 43
  • [5] Prognostic factors for progression of visual field damage in patients with normal-tension on glaucoma
    Nakagami, T
    Yamazaki, Y
    Hayamizu, F
    [J]. JAPANESE JOURNAL OF OPHTHALMOLOGY, 2006, 50 (01) : 38 - 43
  • [6] Prognostic factors for progression of visual field damage in patients with normal-tension glaucoma
    Spaeth, George L.
    [J]. JAPANESE JOURNAL OF OPHTHALMOLOGY, 2007, 51 (02) : 156 - 156
  • [7] Risk factors for visual field progression of normal-tension glaucoma in patients with myopia
    Bae, Hyoung Won
    Seo, Sang Jin
    Lee, Sang Yeop
    Lee, Yun Ha
    Hong, Samin
    Seong, Gong Je
    Kim, Chan Yun
    [J]. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2017, 52 (01): : 107 - 113
  • [8] Relationship between progression of visual field damage and choroidal thickness in eyes with normal-tension glaucoma
    Hirooka, Kazuyuki
    Fujiwara, Atsushi
    Shiragami, Chieko
    Baba, Tetsuya
    Shiraga, Fumio
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 40 (06): : 576 - 582
  • [9] Factors predicting the rate of visual field progression in normal-tension glaucoma eyes with tilted disc
    Kwun, Youngkyo
    Han, Gyule
    Choy, Yoon-Jung
    Kee, Changwon
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [10] Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma
    Sawada, A
    Kitazawa, Y
    Yamamoto, T
    Okabe, I
    Ichien, K
    [J]. OPHTHALMOLOGY, 1996, 103 (02) : 283 - 288